DeepCPI: A Deep Learning-Based Framework for Large-Scale <i>in Silico</i> Drug Screening
Fang Wan(Translational Therapeutics (United States)), Jianyang Zeng(Westlake University), Dehua Yang(National Center for Drug Screening), Antao Dai(Shanghai Institute of Materia Medica), Haipeng Gong(Tsinghua University), Ming‐Wei Wang(Shanghai Medical College of Fudan University), Ligong Chen(Diagnostics for the Real World (United States)), Yue Zhu(Shanghai Institute of Materia Medica), Xiaoqing Cai(Shanghai Institute of Materia Medica), Tian Xia(Huazhong University of Science and Technology), Hailin Hu(Tsinghua University)
Cited by 91
Related Papers
A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information
|Nature Communications|2017|884
G protein-coupled receptors: structure- and function-based drug discovery
|Signal Transduction and Targeted Therapy|2021|626
Allelic reprogramming of 3D chromatin architecture during early mammalian development
|Nature|2017|559